ASX Penny Stocks With Market Caps Over A$100M To Consider

As Australian shares prepare for a modest rise, the local market is closely watching economic indicators such as job advertisements and building approvals, alongside international developments like U.S.-Iran peace talks. For investors considering smaller or newer companies, penny stocks—despite their somewhat outdated name—remain an intriguing area of investment. These stocks can offer surprising value and growth potential when backed by strong financials, making them worth considering for those seeking opportunities beyond the mainstream indices.

Below we spotlight a couple of our favorites from our exclusive screener.

Appen

Simply Wall St Financial Health Rating:★★★★★★

Overview:Appen Limited is an AI lifecycle company offering data sourcing, data annotation, and model evaluation solutions globally, with a market cap of A$332.34 million.

Operations:Appen generates revenue from two main segments: Appen China, contributing $104.11 million, and Appen Global, which accounts for $127.87 million.

Market Cap:A$332.34M

Appen Limited, with a market cap of A$332.34 million, is navigating the challenges typical of penny stocks, including unprofitability and increased losses over the past five years. Despite this, Appen remains debt-free and holds short-term assets of $122.7 million that exceed both its short-term and long-term liabilities. The company has a cash runway extending beyond three years if current free cash flow levels are maintained. Recent collaboration with Hugging Face to enhance the Open ASR Leaderboard highlights its strategic focus on advancing AI benchmarks, potentially strengthening its market position amidst industry shifts toward rigorous evaluation standards.

• Unlock comprehensive insights into our analysis of Appen stock in this financial health report.

• Assess Appen's future earnings estimates with our detailed growth reports.

Clover

Simply Wall St Financial Health Rating:★★★★★★

Overview:Clover Corporation Limited produces, refines, and sells natural oils and encapsulated powders across various regions including Australia, New Zealand, Asia, Europe, the Middle East, and the Americas with a market cap of A$166.07 million.

Operations:Revenue Segments: No specific revenue segments are reported for this company.

Market Cap:A$166.07M

Clover Corporation Limited, with a market cap of A$166.07 million, has shown significant earnings growth of 96.3% over the past year, contrasting its five-year decline. The company is debt-free and maintains stable weekly volatility at 10%. Its short-term assets (A$60.5M) comfortably cover both short-term (A$12.4M) and long-term liabilities (A$1.3M). Recent half-year results reported sales of A$44.09 million and net income of A$4.25 million, indicating improved profit margins from the previous year. Additionally, Clover announced a fully franked dividend distribution and revenue guidance for fiscal 2026 between $92 million to $96 million.